toadfish| Invisible heavy positions in public funds revealed that electronic medicine positions have the highest market value
Zhang Zhibo, a reporter from the Securities Times
According to the comparison between the top ten tradable shareholders of listed companies and the positions of public funds in the first quarter.ToadfishIt can be found that public offering funds report hidden heavy stocks in the first quarter.
Hidden heavy positions of public offering funds
Two major industries
According to the industry at the application level, the market capitalization of the invisible holdings of electronics and pharmaceutical biology exceeded 60 billion yuan in the first quarter, which was 619 respectively.Toadfish81 billion yuan and 60.185 billion yuan, the number of shares is more than 480; the market value of shares in the power equipment industry is then 42.91 billion yuan; and the market value of shares in machinery and equipment, non-bank finance, computers and other sectors is more than 20 billion yuan.
In the electronic sector, public funds have the highest invisible holdings in the semiconductor sector, including Huarun Micro, Tuojing Technology, Shanghai Silicon Industry, Jingchen shares and other stocks with a market capitalization of more than 2 billion yuan. Most of them are held by ETF, but there are exceptions. For example, Nuoan growth mixture, managed by Liu Huiying, entered the list of the top 10 tradable shareholders of Bauhinia Technology and increased its holdings by 221100 shares compared with the previous period.
Liu Huiying said in the fund's quarterly report that the performance of overseas chip stocks has verified that the upward trend of the global semiconductor business cycle has begun, superimposing the long-term industrial trend of domestic substitution of Chinese chips. Domestic chip plate is expected to form a performance and valuation of Davis double-click. The current chip plate investment performance is relatively high, dawn is coming.
Tianfeng Securities also believes that the current semiconductor cycle is in the relative bottom range. The marginal improvement of semiconductor companies increased sharply in the first quarter compared with the same period last year; benefiting from the semiconductor cycle recovery + AI and other application catalysis, superimposed long-term domestic substitution trend, some semiconductor manufacturers ushered in high profit growth and are optimistic that the industry will achieve high growth in the second quarter.
For the pharmaceutical biology sector, fund managers who mainly focus on this direction have also expressed optimism about the future of the industry. Financing fund manager Wan Min said in the first quarterly report of financing Health Industry A that with the advent of the best part of the new round of aging, under the background of the stabilization of the policy framework and the fading of the transient base effect of the suppressing plate, remain optimistic about the medium-and long-term prospects of the plate, the pharmaceutical sector is expected to usher in a dual improvement of fundamentals and policy margin, the plate valuation is expected to be repaired, and there are many segments of the pharmaceutical sector in the trillion market. There is no shortage of structural opportunities.
73 shares gain invisible position
Over 1 billion yuan
In terms of individual stocks, the market value of invisible holdings of 73 shares by public funds exceeds 1 billion yuan. China Construction Corporation and China Shenhua all hold shares with a market value of more than 3 billion yuan. The main shareholders are Castrol Shanghai and Shenzhen 300ETF, Huaxia Shanghai Stock Exchange 50ETF and Yi Fang Da Shanghai and Shenzhen 300ETF. Among them, Huaxia Shanghai 50 ETF increased its holdings in China Construction and China Shenhua 95.6596 million shares and 15.0258 million shares respectively in the first quarter.
In addition, Huarun Micro, Tuojing Technology, Wanhua Chemical, Central Control Technology and other stocks have a market capitalization of more than 2.5 billion yuan.
In terms of shareholdings, public offering funds have invisible holdings of more than 100 million shares in 34 shares, ranking in the top three in China Construction, Hefi Optoelectronics-U and Bank of China, with 632 million shares, 517 million shares and 510 million shares respectively; Tianfeng Securities, China Unicom, Sinopec and China Communications account hold more than 300 million shares.
Judging from the proportion of public offering funds' invisible holdings in the outstanding shares of individual shares, 63 shares account for more than 10%. Essen shares ranked first with 33.74%, Shengke Communications-U ranked second with 26.26%, and Zhi Te Xincai, Zhixiang Jintai-U, Shengmei Shanghai, Melland and Eco Optoelectronics all accounted for more than 20% of the invisible shares.
Essen Co., Ltd. is the main supplier of domestic advanced packaging photoresist matching reagent products, with advanced packaging negative photoresist, OLED photoresist and wafer PSPI as a breakthrough, photoresist products cover wafer manufacturing, advanced packaging and semiconductor display and other application fields. The company achieved a net profit of 7.5101 million yuan in the first quarter, an increase of 112.28% over the same period last year.
High position fund
Invisible heavy stock exposure
From the perspective of public offering funds, excluding ETF funds and LOF funds, Glenn's China Europe Healthcare mixed A has the highest disclosed invisible shareholding market value of 10.176 billion yuan, while the top pharmaceutical stocks are Kailiying, Tiantan Biology, Yifeng Pharmacy, Kyushu Pharmaceutical and General Strategy Medical, all of which are more than 700 million yuan.
Glenn said that looking forward to the second quarter, it is still optimistic about the innovation-driven pharmaceutical industry chain. The policy continues to strengthen the support for innovation in the field of medicine and biology. As an important part of the new quality productivity, pharmaceutical innovation is also the most firm direction of enterprise layout. 2024 is expected to usher in the peak period of approval and marketing of related innovative drugs.
In addition, the market value of the invisible holdings disclosed by Xingquan Herun mixture is 6.024 billion yuan, the market value of its holdings in home furnishings is more than 500 million yuan, and the market value of its holdings in Huitai Medical, Zhejiang Dingli, Juhua and Geke Weiwei is more than 400 million yuan. Ruiyuan growth value mixed A, Merchants Zhong Zheng Liquor Index A has been disclosed that the market capitalization of hidden positions is more than 4.5 billion yuan, the former heavy warehouse of new Zebang, national porcelain materials are more than 400 million yuan; the latter heavy warehouse alcoholic wine, old white dry wine, Shuijingfang, Shunxin agriculture are all more than 600 million yuan.
Tags:
Prev: supernovacasinonodepositbonus| Bailian Shares (600827.SH): Controlling shareholder Bailian Group plans to subscribe for no more than 360 million new domestic shares of Lianhua Supermarket
Next: bestearningblockchaingames| State Council: Make up for shortcomings such as bulk commodities, cold chain, and rural logistics